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To construct an expression vector for Lactococcus lactis, the EmPMT fragment which contained the 
erythromycin resistance gene, P32 promoter, multiple cloning site (MCS) and terminator (T) was 
subcloned into the small cryptic plasmid pAR141. The resulting vector, designated as pAR1411, was 
found to be stably maintained in L. lactis MG1363 after transformation for at least 100 generations 
under non-selective conditions. The vector was also demonstrated to be able to express the gene 
coding for chloramphenicol acetyltransferase (cat) in L. lactis. 
 





Lactococcus lactis is one of the best characterized lactic 
acid bacteria (LAB) and is widely used as a dairy starter 
culture traditionally. The extensive knowledge and the 
advancement of molecular biology techniques for this 
bacterium have not only enhanced its performance in 
dairy production, but also expanded its potential appli-
cation in other areas (Konings et al., 2000). Due to its 
generally regarded as safe (GRAS) stature, this Gram-
positive food-grade bacterium has been used as cell 
factories for the production of various chemicals for food 
industry (Luoma et al., 2001), pharmaceutical 
(Bermúdez-Humarán et al., 2003) and neutraceutical 
(Hugenholtz and Smid, 2002), in addition to being 
developed for vaccine delivery (Ramasamy et al., 2006; 
van Roosmalen et al., 2006; Mercenier et al., 2000). Re-
combinant L. lactis has also been used for the expression 
of several viral and eukaryotic proteins (Kunji et al., 2003; 
Madsen et al., 1999). Recently, the potential of L. lactis in 
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Most of these applications of L. lactis require the use of 
cloning and expression vectors for the introduction of 
foreign genes or genetic manipulations of the hosts. 
These vectors were generally derived from cryptic plas-
mids (Shareck et al., 2004; de Vos and Simons, 1994). 
Cryptic plasmids are extrachromosomal DNA elements 
that encode no recognizable phenotype besides their 
replication functions. Selectable markers are then in-
corporated into these plasmids to enable recombinant 
bacteria carrying them to be scored easily. The present 
study reported the construction of a constitutive expres-




MATERIALS AND METHODS 
 
Bacterial strains, plasmids and growth conditions 
 
Bacterial strains and plasmids used in this study are listed in Table 
1. L. lactis and Escherichia coli strains were cultured in GM17 
(Terzaghi and Sandine, 1975) and LB (Sambrook and Russell, 
2001) at 30 and 37°C, respectively. For L. lactis, erythromycin and 
chloramphenicol were used at a final concentration of 5 and 7.5 µg 
ml-1. For E. coli, erythromycin at a concentration of 150 µg ml-1 was 
used. 
Plasmids were isolated from  Lactococcal  strains  using  alkaline 
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Table 1. Bacterial strains and plasmids used in this study.  
 
Strains/Plasmids Relevant characteristics Source/Reference 
Strains   
L. lactis subsp. cremoris MG1363 Plasmid-free strain Gasson, 1983 
L. lactis subsp. lactis M14 Milk isolate, natural host of pAR141 Raha et al., 2006 
E. coli TOP10 Cloning host Invitrogen 
E. coli XL1Blue Cloning host Stratagene 
   
Plasmids   
pMG36e 3.6 kbp, Ermr van de Guchte et al., 1989 
pNZ8048 3.3 kbp, Chlr Kuipers et al., 1998 
pAR141 1.6 kbp, cryptic plasmid Raha et al., 2006 
pAR1411 3.2 kbp, Ermr, pAR141 derivative 
containing EmPMT fragment  
This study 
pAR1411-cat 3.9 kbp, Ermr, Chlr, pAR1411 derivative 





analysis method (Sambrook and Russell, 2001). The only 
difference was that the growth medium for strains containing 
plasmid with anti-biotic resistance gene was supplemented with the 
appropriate antibiotic for the selection of plasmid-bearing cells. 
Analyses were carried out by agarose gel electrophoresis. 
 
 
PCR Amplification of EmPMT Fragment from pMG36e and 
transformation into L. lactis  
 
PCR was used to amplify a fragment (EmPMT) containing an 
erythromycin resistance gene (ermC), constitutive promoter P32, 
multiple cloning site (MCS) and terminator T from pMG36e (van de 
Guchte et al., 1989) using EM1 (5-CGA CAT ACT GTT CTT CCC-
3) and EM2 (5-AAC CGT TTC TAC TCA ATG-3) primers. The 50 
µl PCR reaction mix comprised of 1× PCR Buffer with MgSO4 
(Fermentas), 0.2 mM of dNTP Mix (Fermentas), 0.08 mM of each 
EM1 and EM2 primers, 200 ng of pMG36e and 1.25 U of Pfu DNA 
polymerase (Fermentas). The PCR conditions were: initial dena-
turation at 95°C for 5 min, followed by 25 cycles of denaturation at 
95°C for 1 min, annealing at 53°C for 1 min, extension at 72°C for 3 
min, and ended by final extension at 72°C for 10 min. The PCR 
product was then analysed with agarose gel electrophoresis. 
The EmPMT fragment was cloned into the unique FspI site of 
pAR141 (Raha et al., 2006) with T4 DNA ligase (Fermentas). The 
ligation mix was transformed into competent L. lactis MG1363 by 
electroporation as described by Holo and Nes (1989) with minor 
modification. The electroporation was carried out with GenePulser 
(Bio-Rad; 2.3 kV, 25 µF and 200 ) and the transformants were 
screened on SGM17 (GM17 supplemented with 0.5 M sucrose) 
containing erythromycin after incubation at 30°C for 24 to 48 h. The 
recombinant plasmid was then isolated and verified by restriction 
enzyme digestion analysis. The stability of the recombinant plasmid 
was tested as described previously (Raha et al. 2006).  
 
 
Transformation into E. coli 
 
The newly constructed plasmid was then transformed into E. coli 
TOP10 and XL1-Blue competent cells using standard heat-shock 
method as described by Sambrook and Russell (2001). A widely 
used lactococcal shuttle vector pMG36e was used as the positive 
control for transformation. Transformants were selected from LB 
agar plates containing 150 g/ml of erythromycin after overnight 
incubation at 37°C. Erythromycin resistant transformants were 
subjected to plasmid extraction followed by RE digestion analysis 
and PCR screening. 
 
 
Cloning and expression of heterologous gene in pAR1411 
 
Primers were designed to isolate the chloramphenicol acetyltrans-
ferase cat gene from a lactococcal vector pNZ8048. The open 
reading frame (ORF) of chloramphenicol acetyltransferase (cat) 
gene was PCR amplified from pNZ8048 using CmF (5-GGC TCT 
AGA TAT GAA CTT TAA TAA AAT TGA TTT AG-3) and CmR (5-
AAT CTG CAG TTA TAA AAG CCA GTC ATT AGG-3) primers that 
contain Xba I and Pst I site at their respective 5-end. The PCR 
conditions used were: initial denaturation at 95°C for 5 min, 25 
cycles of denaturation at 95°C for 1 min, annealing at 60°C for 1 
min, extension at 72°C for 1 min, and final extension at 72°C for 10 
min. The PCR product was analysed by agarose gel electro-
phoresis, cloned into pAR1411 and transformed into L. lactis 
MG1363 as described above. The transformants were selected on 
SGM17 agar containing erythromycin, chloramphenicol or both. The 




Verification of insertion of cat gene in pAR1411 
 
Single colonies of transformants were subcultured in SGM17 broth 
standing culture containing erythromycin and chloramphenicol, or 
only chloramphenicol at 30°C.  Plasmid DNA was then extracted 
from the culture. The insertion of cat gene in pAR1411 in the 
putative recombinant plasmid was verified through RE digestion 
analysis with PstI and XbaI. The RE digests were then subjected to 





Each of the erythromycin resistant transformants selected  
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Figure 2. Analysis of putative recombinant plasmids digested 
with HindIII and Eco321. Lane M: GeneRuler™ DNA Ladder 
Mix (Fermentas); Lanes 1 and 2: putative pAR1411 from L. 
lactis; Lane a: HindIII-digested samples; Lane b: Eco321-
digested samples; Lane c: undigested samples. The arrows 
showed the expected bands of HindIII digest. The yield of two 
visible bands of ~0.7 and ~2.5 kbp reveals that the ermC was 
in the same orientation with the repA and repB genes. 
was found to contain a single plasmid that was larger 
than pAR141. The calculated size of the recombinant 
plasmid was about 3.2 kbp. Restriction enzyme analysis 
of these plasmids recovered from erythromycin resistant 
L. lactis transformants showed that the 1.6 kbp blunt-
ended EmPMT fragment has been successfully cloned 
into pAR141. Digestion with HindIII yielded two visible 
fragments of ~0.7 and ~2.5 kb, which indicated that the 
ermC gene was in the same orientation with the repA and 
repB genes of pAR141 (Figures 1 and 2). Constructs with 
resistance and replication genes in opposite direction, 
which would have given rise to two detectable fragments 
of ~1.4 and ~1.8 kb, were not obtained. This newly con-
structed plasmid vector was designated as pAR1411. 
Plasmid stability test showed that pAR1411 was highly 
stable (~100%) in L. lactis for at least 100 generations 
under non-selective conditions. However, after several 
attempts, pAR1411 could not be recovered from the E. 
coli erythromycin resistant transformants. 
In order to examine the usefulness of pAR1411 as a 
cloning and expression vector, a gene coding for 
chloramphenicol was selected as the reporter marker. 
The cat gene was isolated from pNZ8048 by PCR ampli-
fication, devoid of its transcriptional and translational 
signals. Both the amplicon and pAR1411 were digested 
with PstI and XbaI. The open reading frame of the cat 
gene (~0.7 kb) was then cloned in-frame with the P32 
promoter in pAR1411, producing the contstruct pAR1411- 







Figure 2. Restriction enzyme analysis of putative recombinant plasmid pAR1411-cat for 
verification. Lane M: GeneRuler™ DNA Ladder Mix (Fermentas); Lane 1: Undigested 
pAR1411-cat; Lane 2: pAR1411-cat digested with Pst I; Lane 3: pAR1411-cat digested with 
Xba I; Lane 4: pAR1411-cat digested with PstI and XbaI; Lane 5: pAR1411; Lane 6: 





cat, and transformed into L. lactis MG1363. Initially, a 
total of 28 transformants were recovered from SGM17 
agar plate containing erythromycin (5 g/ml), but not on 
the SGM17 with erythromycin (5 g/ml) and chloram-
phenicol (7.5 g/ml). Interestingly, after two subsequent 
transfers, one colony grew in the broth medium con-
taining both antibiotics. Plasmid extraction revealed that 
this erythromycin and chloramphenicol-double resistant 
strain contained a plasmid bearing the expected mole-
cular size. The putative recombinant plasmid pAR1411-
cat was further verified through RE digestion analysis 
Digestion analyses indicated that the plasmid extracted 
from the transformant harbored the expected fragment 





A lactococcal cloning and expression vector was con-
structed based on the indigenous plasmid pAR141. pAR 
141 is a small plasmid isolated from L. lactis subsp. lactis 
M14 (Raha et al., 2006). Detailed examination of the 
plasmid sequence revealed that this cryptic plasmid only 
carried genes essential for its own replication. There are 
no selection markers which would enable the strains 
harboring it to be scored. In addition, pAR141 also 
contained limited unique RE sites for use in cloning. 
These features of pAR141 restricted its use as a cloning 
vector. Therefore, in this study a fragment from the L. 
lactis expression vector pMG36e was introduced into 
pAR141 to produce a cloning and expression vector, pAR 
1411. Based on the sequence of pMG36e, primers were 
carefully designed to amplify the whole fragment of 
complete erythromycin resistance gene (ermC) including 
its expression signals, and the multiple cloning sites 
together with the promoter P32 and terminator (T) sequen-
ces. The other nonessential sequence was minimized to 
keep the newly constructed plasmid as small as possible. 
Antibiotic resistance is generally used as a selection 
marker due to its easy selection. However, antibiotic 
resistance genes are not commonly present in lacto-
coccal plasmids. Although several plasmids in L. lactis 
had been studied, many of these plasmids turned out to 
be cryptic (McKay, 1983), including pWV01 (Leenhouts et 
al., 1991), pSH1 (Gasson, 1983) and pAR141 (Raha et 
al., 2006). Only a limited number of the identified plas-
mids such as pAJ01 (Raha et al., 2002) encoded 
antibiotic resistances. Therefore, the erythromycin 
resistance marker, ermC which originated from Staphylo-






has been shown to express in L. lactis, Bacillus. subtilis 
and E. coli efficiently and utilized in various constructions 
of lactococcal plasmid vectors (de Vos and Simons, 
1994).  
Since pAR141 possess limited number of unique RE 
sites, a fragment constituting several restriction enzyme 
recognition sites was added to enhance cloning. With the 
addition of the multiple cloning sites, cloning of genes into 
the vector would be made easier as there are more 
choices of RE sites. Directional cloning could also be 
performed where two different REs are used to orientate 
the insertion and the problem of inappropriate insertions 
can also be avoided. 
In addition to the selection marker and MCS, the 
constitutive P32 promoter and transcriptional terminator of 
pMG36e (van de Guchte et al., 1989) were also incurpo-
rated into pAR1411. These two gene expression signals 
flanked the MCS of pMG36e. Although useful, the 
constitutive promoter P32 which originated from the chro-
mosome of L. lactis subsp. cremoris Wg2 is not a very 
strong promoter (van der Vossen et al., 1987). This may 
be caused by the difference in two nucleotides in the 
sequence of P32 from the consensus in the -35 region 
(van der Vossen et al., 1987). The fragment also encom-
passed the RBS sequence (GGAGG) and the 5-end of 
the orf32 gene. 
The transcriptional terminator used in pAR1411 
originated from the proteinase gene of plasmid pWV05 of 
L. lactis Wg2 (Kok et al., 1988). The terminator consisted 
of two complementary IRs which could form a stem of 15 
bp followed by a stretch of T’s, which are the features of 
a rho-independent terminator. It is beneficial to have a 
transcriptional terminator downstream of the site in which 
to clone foreign genes (Stueber and Bujard, 1982). This 
could prevent read-through of the promoter to the repli-
cation region and affect the plasmid replication and its 
stability. 
During the construction of the recombinant vector from 
the cryptic plasmid pAR141, care was taken that the 
replication function of the plasmid was not disturbed. The 
repA, repB genes and the sequence encoding dso are 
essential features for plasmid replication and main-
tenance. The successful transformation and recovery of 
pAR1411 in L. lactis indicated that the unique FspI site 
used for the insertion of pMG36e fragment is not located 
within the region important for replication of the plasmid. 
This observation also appeared as evidence that plas-
mids from L. lactis subsp. lactis could replicate in subsp. 
cremoris. 
The replication of the recombinant plasmid pAR1411 in 
E. coli strains was tested. However, pAR1411 failed to be 
retrieved from the transformants. In some instances, 
plasmids isolated from the transformants showed diffe-
rences in sizes and RE patterns as compared to the 
pAR1411 obtained from L. lactis. Most of the time, no 
plasmid   could   be  extracted  from  the  cells.  This  was 




unexpected because based on sequence similarity to 
pWV01 (Leenhouts et al., 1991), pAR141 and its 
derivative should be functional in a wide range of bacteria. 
These may indicate the structural and segregational 
instability of the construct in E. coli. The functionality of 
the replication system of this plasmid might be another 
point for these results. The possibility of contamination of 
the transformants was low as the control reaction with 
pMG36e was successful. 
To test the functionality of the construct pAR1411 as 
cloning and expression vector in L. lactis, the cat gene 
conferring chloramphenicol resistantance was used. The 
use of antibiotic resistance gene as the reporter provided 
an easy selection of recombinants expressing the inframe 
inserted DNA. The cat gene has been used as a reporter 
gene in B. subtilis and L. lactis for the screening of 
promoters and transcriptional terminators (van der 
Vossen et al., 1985). The problems of low yield of trans-
formants with double resistance encountered during the 
attempts of expression might be caused by several 
factors. The higher yield on the agar plates with erythro-
mycin selection alone indicated that the electrotransfor-
mation processes were successful. However, a majority 
of these transformants were erythromycin sensitive 
indicating that the plasmid might have undergone self-
ligation. This might be improved by using higher ratio of 
insert to vector in the ligation, or by dephosphorylation of 
the vector with calf/shrimp alkaline phosphatase to 
reduce self-ligation. At the same time, the failure to 
recover transformants on the agar plates supplemented 
with both antibiotics might be due to the high concen-
trations of the antibiotics. Kok et al. (1984) used only 5 
and 1 g/ml of chloramphenicol and erythromycin, res-
pectively, while in this study, the concentrations were 7.5 
and 5 g/ml. These researchers also showed that 
reduced concentrations of antibiotics were required 
during selection in E. coli when plasmid with these two 
resistant markers was used. 
A recombinant plasmid pAR1411-cat containing cat 
gene was successfully recovered from the L. lactis trans-
formants. Although SDS-polyacrimide gel electrophoresis 
was not carried out to demonstrate the production of the 
CAT protein, the ability of the transformants to grow on 
the chloramphenicol-containing agar plate was a strong 
evidence that a functional substance conferring resis-
tance to the antibiotic was present and expressed in the 
strain.  
In conclusion, a recombinant vector pAR1411 was con-
structed by subcloning the EmPMT fragment from 
pMG36e into pAR141. This construct could replicate in L. 
lactis, but was found to be unable to transform the E. coli 
strains tested. pAR1411 could be used to clone and 
express catalase acetyltransferase, a heterologous repor-
ter protein, in L. lactis. The expression vector could be 
further developed and improved to serve different 
purpose. 
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